Meiji Pharmaceutical University · Unclassified · 准教授

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Use of a mouse–human chimeric anti-α-galactosidase A monoclonal antibody as a reference for measuring serum antidrug antibody titers in patients with Fabry disease.2025 · Mol. Genet. Metab., 144, 109000, 2025.
• Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice.2024 · Mol. Genet. Metab. Rep., 40, 101118, 2024
• Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?2024 · Mol. Genet. Metab. Rep., 39, 101079, 2024.
• Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients.2024 · Intern. Med., 63, 1531-1537, 2024.

• Official profile